astrazeneca glp-1 ADA: AZ's oral shows 'competitive efficacy' in phase 2 AstraZeneca's Oral GLP-1 Pill To

20, the firm surveyed more than 600 participants who are currently taking a GLP-1, considering the therapy or have taken it in the past but no longer do

Surgery is available as a last resort to treat intractable peripheral vertigo

Organs such as brain and heart, with high rates of oxygen consumption and limited respiration levels, are particularly vulnerable to this phenomenon, hence partially explaining the high prevalence of cardiovascular diseases (CVD) and neurological disorders in elderly (Corbi et al., 2008)

The Longevity Paradox: Weight Loss at What Cost

By reducing melanin synthesis, it helps fade existing dark spots and prevents new hyperpigmentation